SE9804003D0 - A method of producing drug particles - Google Patents

A method of producing drug particles

Info

Publication number
SE9804003D0
SE9804003D0 SE9804003A SE9804003A SE9804003D0 SE 9804003 D0 SE9804003 D0 SE 9804003D0 SE 9804003 A SE9804003 A SE 9804003A SE 9804003 A SE9804003 A SE 9804003A SE 9804003 D0 SE9804003 D0 SE 9804003D0
Authority
SE
Sweden
Prior art keywords
drug particles
producing drug
producing
susceptible
degradation
Prior art date
Application number
SE9804003A
Other languages
English (en)
Swedish (sv)
Inventor
Catherine Boissier
Anne Mari Juppo
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9804003A priority Critical patent/SE9804003D0/xx
Publication of SE9804003D0 publication Critical patent/SE9804003D0/xx
Priority to US09/486,688 priority patent/US6596315B1/en
Priority to DK99963729T priority patent/DK1133283T3/da
Priority to JP2000583496A priority patent/JP4612191B2/ja
Priority to ES99963729T priority patent/ES2228148T3/es
Priority to AU20102/00A priority patent/AU754385B2/en
Priority to PCT/SE1999/002152 priority patent/WO2000030612A1/en
Priority to AT99963729T priority patent/ATE278390T1/de
Priority to DE69920945T priority patent/DE69920945T2/de
Priority to CA002349711A priority patent/CA2349711C/en
Priority to EP99963729A priority patent/EP1133283B1/en
Priority to PT99963729T priority patent/PT1133283E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
SE9804003A 1998-11-23 1998-11-23 A method of producing drug particles SE9804003D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles
PT99963729T PT1133283E (pt) 1998-11-23 1999-11-22 Um metodo de producao de particulas de farmaco
ES99963729T ES2228148T3 (es) 1998-11-23 1999-11-22 Metodo de produccion de particulas de farmacos.
DK99963729T DK1133283T3 (da) 1998-11-23 1999-11-22 Fremgangsmåde til fremstilling af lægemiddelpartikler
JP2000583496A JP4612191B2 (ja) 1998-11-23 1999-11-22 薬物粒子の製造方法
US09/486,688 US6596315B1 (en) 1998-11-23 1999-11-22 Method of producing drug particles
AU20102/00A AU754385B2 (en) 1998-11-23 1999-11-22 A method of producing drug particles
PCT/SE1999/002152 WO2000030612A1 (en) 1998-11-23 1999-11-22 A method of producing drug particles
AT99963729T ATE278390T1 (de) 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln
DE69920945T DE69920945T2 (de) 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln
CA002349711A CA2349711C (en) 1998-11-23 1999-11-22 A method of producing drug particles
EP99963729A EP1133283B1 (en) 1998-11-23 1999-11-22 A method of producing drug particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles

Publications (1)

Publication Number Publication Date
SE9804003D0 true SE9804003D0 (sv) 1998-11-23

Family

ID=20413380

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles

Country Status (12)

Country Link
US (1) US6596315B1 (xx)
EP (1) EP1133283B1 (xx)
JP (1) JP4612191B2 (xx)
AT (1) ATE278390T1 (xx)
AU (1) AU754385B2 (xx)
CA (1) CA2349711C (xx)
DE (1) DE69920945T2 (xx)
DK (1) DK1133283T3 (xx)
ES (1) ES2228148T3 (xx)
PT (1) PT1133283E (xx)
SE (1) SE9804003D0 (xx)
WO (1) WO2000030612A1 (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AUPR197000A0 (en) * 2000-12-08 2001-01-11 Unisearch Limited Synthesis of small particles
AU2002221320B2 (en) * 2000-12-08 2006-06-15 The University Of Sydney Synthesis of small particles
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
WO2003072127A1 (en) 2002-02-25 2003-09-04 Phasex Corporation Method for drying water-borne materials
EP1499296B1 (en) 2002-04-15 2012-04-04 MAP Pharmaceuticals Inc Formulation of fine particles using liquefied or dense gases
AU2003262992A1 (en) 2002-08-30 2004-03-19 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
EP1624862B1 (en) 2003-05-08 2014-12-31 Nektar Therapeutics Particulate materials
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1904219A4 (en) 2005-07-15 2011-07-27 Map Pharmaceuticals Inc METHOD FOR FORMING PARTICLES
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
EP2425819A1 (en) 2007-02-11 2012-03-07 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (de) 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
HU209603B (en) * 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
WO1994008599A1 (en) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
BR9510510A (pt) * 1994-12-22 1998-07-07 Astra Ab Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia
AU709262B2 (en) * 1995-10-17 1999-08-26 Board Of Regents, The University Of Texas System Insoluble drug delivery
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer

Also Published As

Publication number Publication date
JP4612191B2 (ja) 2011-01-12
JP2002530317A (ja) 2002-09-17
EP1133283A1 (en) 2001-09-19
ES2228148T3 (es) 2005-04-01
CA2349711A1 (en) 2000-06-02
CA2349711C (en) 2008-07-15
AU2010200A (en) 2000-06-13
EP1133283B1 (en) 2004-10-06
DE69920945T2 (de) 2005-08-25
DK1133283T3 (da) 2005-01-24
DE69920945D1 (de) 2004-11-11
WO2000030612A1 (en) 2000-06-02
US6596315B1 (en) 2003-07-22
PT1133283E (pt) 2005-01-31
ATE278390T1 (de) 2004-10-15
AU754385B2 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
SE9804003D0 (sv) A method of producing drug particles
ATE364620T1 (de) Amphotere sterole und deren verwendung
NO20003139D0 (no) FremgangsmÕte for syntese av 1,3-dioler
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
IS5884A (is) Aðferð til framleiðslu á hreinu sítalóprami
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
NO981688D0 (no) Chirale metylfenyloksazolidinoner
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
BRPI0112375B8 (pt) aplidinas como derivados antitumorais
NO990596D0 (no) FremgangsmÕte for drift av en olje- og gassproduksjonsbr°nn aktivisert av et pumpesystem
DE1169296T1 (de) Niedrigdruckreaktor zur herstellung von aminen
ATE237568T1 (de) Neue substanzbibliothek und damit hergestellte supramolekulare komplexe
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
PL367981A1 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
DE69917440D1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.